{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-005469","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2025-02-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.629383+00:00","generated_at":"2026-05-27T00:57:50.207492+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Avon Freight Group selects INBS fingerprint drug testing for 3 UK sites","bullets":["Avon Freight Group selects INBS fingerprint drug testing for random testing across three UK sites.","INBS now serves over 400 accounts in 19 countries; targeting U.S. expansion after FDA 510(k) submission in Dec 2024.","UK drug testing market projected to reach $453M by 2030, positioning INBS for growth.","Avon previously used external oral swab tests; switch aims for less invasive, cost-effective solution."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-005469","json":"https://secwatch.observer/filing/0001493152-25-005469.json","markdown":"https://secwatch.observer/filing/0001493152-25-005469.md","text":"https://secwatch.observer/filing/0001493152-25-005469.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315225005469/0001493152-25-005469-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315225005469/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T00:57:50.207492+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}